VYNT Share Price Performance
US$0
0.00 (0.00%)
Price US$0
Share Pricen/a
Vyant Bio, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
VYNT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Vyant Bio, Inc. Key Details
Last Reported Earnings
Jun 30, 2023
Next Reporting Earnings
n/a
- -2.06
- -85.39%
- -3,281.86%
- 1.3%
About VYNT
- Founded
- n/a
- Employees
- 4
- CEO
- WebsiteView website
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company’s central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson’s disease (PD). The company is based in Cherry Hill, New Jersey.
